These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25330843)

  • 1. First-trimester screening for preeclampsia: impact of maternal parity on modeling and screening effectiveness.
    Moon M; Odibo A
    J Matern Fetal Neonatal Med; 2015; 28(17):2028-33. PubMed ID: 25330843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
    Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
    Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia.
    Goetzinger KR; Zhong Y; Cahill AG; Odibo L; Macones GA; Odibo AO
    J Ultrasound Med; 2013 Sep; 32(9):1593-600. PubMed ID: 23980220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal characteristics.
    Goetzinger KR; Cahill AG; Kemna J; Odibo L; Macones GA; Odibo AO
    Prenat Diagn; 2012 Oct; 32(10):1002-7. PubMed ID: 22847849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of screening for hypertensive disorders of pregnancy at 11-13 weeks in a Scandinavian population.
    Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
    Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1238-47. PubMed ID: 25146367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester prediction of preeclampsia in nulliparous women at low risk.
    Myatt L; Clifton RG; Roberts JM; Spong CY; Hauth JC; Varner MW; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Iams JD; Sciscione A; Harper M; Tolosa JE; Saade G; Sorokin Y; Anderson GD;
    Obstet Gynecol; 2012 Jun; 119(6):1234-42. PubMed ID: 22617589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks.
    Poon LC; Stratieva V; Piras S; Piri S; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):216-23. PubMed ID: 20108221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-Trimester Placental Growth Factor for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndromes Cohort Study.
    Boutin A; Demers S; Gasse C; Giguère Y; Tétu A; Laforest G; Bujold E
    Fetal Diagn Ther; 2019; 45(2):69-75. PubMed ID: 30304731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia.
    Odibo AO; Zhong Y; Goetzinger KR; Odibo L; Bick JL; Bower CR; Nelson DM
    Placenta; 2011 Aug; 32(8):598-602. PubMed ID: 21652068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms.
    Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
    BJOG; 2015 Dec; 122(13):1781-8. PubMed ID: 25471057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia.
    Kuc S; Koster MP; Franx A; Schielen PC; Visser GH
    PLoS One; 2013; 8(5):e63546. PubMed ID: 23717445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.
    Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM
    Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.
    Akolekar R; Syngelaki A; Beta J; Kocylowski R; Nicolaides KH
    Prenat Diagn; 2009 Dec; 29(12):1103-8. PubMed ID: 19777530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second Trimester Screening of Preeclampsia Using Maternal Characteristics and Uterine and Ophthalmic Artery Doppler.
    Praciano de Souza PC; Gurgel Alves JA; Bezerra Maia E Holanda Moura S; Araujo Júnior E; Martins WP; Da Silva Costa F
    Ultraschall Med; 2018 Apr; 39(2):190-197. PubMed ID: 27300275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.